Press Announcements

Note: Press announcements from 2004-2012, 2013-2016, 2017, 2018-2020, 2021, 2022, and 2023 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.

March 2025

• March 4, 2025 - FDA Roundup: March 4, 2025

February 2025

• February 28, 2025 - FDA Roundup: February 28, 2025
• February 21, 2025 - FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
• February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
• February 5, 2025 - FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

January 2025

• January 30, 2025 - FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
• January 17, 2025 - FDA Roundup: January 17, 2025
• January 16, 2025 - FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review
• January 15, 2025 - FDA Proposes Significant Step Toward Reducing Nicotine to Minimally or Nonaddictive Level in Cigarettes and Certain Other Combusted Tobacco Products
• January 14, 2025 - FDA Proposes Requiring At-a-Glance Nutrition Information on the Front of Packaged Foods

Pagination

• First page « First
• Previous page ‹‹
• …
• Page 5
• Page 6
• Page 7
• Page 8
• Current page 9
• Page 10
• Page 11
• Page 12
• Page 13
• …
• Next page ››
• Last page Last »